MVEC has recently updated its RSV reference page with a new FAQ addressing whether there is an increased risk of preterm birth associated with RSV vaccines in pregnancy.
Current data has not demonstrated a statistically significant risk of preterm birth associated with Abrysvo. A trial of a different RSV vaccine was halted due to a difference in the number of preterm births in the vaccine group compared with the placebo group.
Find MVEC’s detailed answer in the ‘Commonly asked questions’ section of the एमवीईसी: रेस्पिरेटरी सिंकाइटियल वायरस (आरएसवी) reference page, under the question ‘Is there an increased risk of preterm birth associated with RSV vaccine in pregnancy’.